Immune Correlates and Long Term Follow Up of a Phase Ia Study of Mpdl3280A, an Engineered Pd-L1 Antibody, in Patients with Metastatic Renal Cell Carcinoma (Mrcc)

D.F. McDermott; M. Sznol; J.A. Sosman; J-C. Soria; M.S. Gordon; O. Hamid; J. Delord; M. Fasso; Y. Wang; J. Bruey; G. Fine; T. Powles

Journal ArticleOPEN ACCESS

Immune Correlates and Long Term Follow Up of a Phase Ia Study of Mpdl3280A, an Engineered Pd-L1 Antibody, in Patients with Metastatic Renal Cell Carcinoma (Mrcc)

McDermott D
Sznol M
Sosman J
et al.

Annals of Oncology (2014) 25 iv280

DOI: 10.1093/annonc/mdu337.2

N/ACitations

9Readers

Get full text

Abstract

Thirteenth International Kidney Cancer Symposium, Chicago, Illinois, USA, 24–25 October 2014

Cite

CITATION STYLE

APA

McDermott, D. F., Sznol, M., Sosman, J. A., Soria, J.-C., Gordon, M. S., Hamid, O., … Powles, T. (2014). Immune Correlates and Long Term Follow Up of a Phase Ia Study of Mpdl3280A, an Engineered Pd-L1 Antibody, in Patients with Metastatic Renal Cell Carcinoma (Mrcc). Annals of Oncology, 25, iv280. https://doi.org/10.1093/annonc/mdu337.2

Immune Correlates and Long Term Follow Up of a Phase Ia Study of Mpdl3280A, an Engineered Pd-L1 Antibody, in Patients with Metastatic Renal Cell Carcinoma (Mrcc)

Abstract

Cite

Register to see more suggestions